Literature DB >> 2849121

Can WR-2721 be improved upon?

D Q Brown1, W J Graham, L J MacKenzie, J W Pittock, L M Shaw.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2849121     DOI： 10.1016/0163-7258(88)90057-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  14 in total

1.  Amino acids and their derivatives as radioprotective agents.

Authors:  J C Roberts
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

2.  In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.

Authors:  C C Verstappen; A A Geldof; T J Postma; J J Heimans
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

Review 3.  Emerging drug treatments for solid tumours.

Authors:  J H Schellens; L C Pronk; J Verweij
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 4.  WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.

Authors:  M Treskes; W J van der Vijgh
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 5.  Pharmacologic approaches to protection against radiation-induced lethality and other damage.

Authors:  J F Weiss
Journal:  Environ Health Perspect       Date:  1997-12       Impact factor: 9.031

6.  Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in mice.

Authors:  A E Korst; E Boven; M L van der Sterre; A M Fichtinger-Schepman; W J van der Vijgh
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 7.  Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.

Authors:  Vijay K Singh; Patricia L P Romaine; Thomas M Seed
Journal:  Health Phys       Date:  2015-06       Impact factor: 1.316

Review 8.  Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

9.  Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice.

Authors:  Sanchita P Ghosh; Shilpa Kulkarni; Michael W Perkins; Kevin Hieber; Roli L Pessu; Kristen Gambles; Manoj Maniar; Tzu-Cheg Kao; Thomas M Seed; K Sree Kumar
Journal:  J Radiat Res       Date:  2012-06-06       Impact factor: 2.724

10.  Radioprotective Potential of Plants and Herbs against the Effects of Ionizing Radiation.

Authors:  Ganesh C Jagetia
Journal:  J Clin Biochem Nutr       Date:  2007-03       Impact factor: 3.114
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.